188 related articles for article (PubMed ID: 15058020)
1. [Evaluation of specific humoral response to hepatitis C core antigen in children].
Kupś J; Woźniakowska-Gesicka T
Przegl Lek; 2003; 60(12):802-5. PubMed ID: 15058020
[TBL] [Abstract][Full Text] [Related]
2. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
[TBL] [Abstract][Full Text] [Related]
3. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
[TBL] [Abstract][Full Text] [Related]
6. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
7. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
8. HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies.
el-Gohary A; Hosny AM; Fawaz N; Heiba A; Abdalla E; Kawano F; Kiyokawa T
Jpn J Infect Dis; 1999 Jun; 52(3):113-6. PubMed ID: 10507990
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.
Tanaka E; Ohue C; Aoyagi K; Yamaguchi K; Yagi S; Kiyosawa K; Alter HJ
Hepatology; 2000 Aug; 32(2):388-93. PubMed ID: 10915747
[TBL] [Abstract][Full Text] [Related]
10. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
11. Antigenic relevance of F protein in chronic hepatitis C virus infection.
Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
[TBL] [Abstract][Full Text] [Related]
12. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
13. [Clinical value of the detection of hepatitis C virus core antigen].
Lu YC; Jiang ZY; Kuang YL; Chen WS; Tan YZ; Li DR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):635-7. PubMed ID: 17618587
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
Alzahrani AJ
J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
[TBL] [Abstract][Full Text] [Related]
16. Total HCV core antigen assay. A new marker of HCV viremia and its application during treatment of chronic hepatitis C.
Lorenzo J; Castro A; Aguilera A; Prieto E; López-Calvo S; Regueiro B; Pedreira J
J Virol Methods; 2004 Sep; 120(2):173-7. PubMed ID: 15288960
[TBL] [Abstract][Full Text] [Related]
17. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Chu CM; Sheen IS; Liaw YF
Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
20. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.
Moreno M; Pérez-Alvarez R; Rodrigo L; Pérez-López R; Suárez-Leiva P
J Viral Hepat; 2006 Jan; 13(1):28-33. PubMed ID: 16364079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
